跳到正文
原文
The Lancet Respiratory Medicine· Eugenio De Corso, Giancarlo Ottaviano, Veronica Seccia, Carlotta Pipolo, Frank Rikki Mauritz Canevari, Giandomenico Maggiore, Elena Cantone, Fabio Pagella, Francesca Anastasi, Ernesto Pasquini, Sara Torretta, Massimiliano Garzaro, Stefania Gallo, Antonella Loperfido, Luca D’Ascanio, Antonio Moffa, Carlo Cavaliere, Mario Caruso, Roberta Anzivino, Gianluca Fadda, Francesco Maria Passali, Lucia Iannuzzi, Anastasia Urbanelli, Giovanni Leo Tomacelli, Salvatore Poma, Marco Corbò, Claudio Montuori, Leandro Maria D’Auria, Jacopo Galli, Ignazio La Mantia, ENT Biologic Italian study group (PolyData Forum)·· 2026-08-19AI 评分35

Mepolizumab 在意大利重度未控制慢性鼻窦炎伴鼻息肉患者中的有效性:MEPOREAL 真实世界多中心 4 期试验

[Articles] Mepolizumab effectiveness for patients with severe, uncontrolled chronic rhinosinusitis with nasal polyps in Italy (MEPOREAL): a real-life, multicentre, phase 4 trial

AI 导读

MEPOREAL 真实世界多中心 4 期试验显示,Mepolizumab 治疗意大利重度未控制慢性鼻窦炎伴鼻息肉患者,在治疗最初 12 个月内结局逐步改善。研究团队认为,仍需长期前瞻性研究进一步阐明治疗 12 个月后的缓解率与控制情况。

来源:The Lancet Respiratory Medicine · thelancet.com